Amir Rashid

University of Cambridge

Papers

3

Total Citations

12

H-Index

2

About

Amir Rashid is a urologic surgeon and researcher whose work focuses on optimizing functional outcomes following robot-assisted radical prostatectomy (RARP) for prostate cancer. His key research areas include post-operative erectile function recovery, surgical safety protocols, and evidence-based reduction of unnecessary interventions. Rashid’s major contributions center on the timing and efficacy of phosphodiesterase-5 inhibitor (PDE5i) therapy after RARP. In his most cited work (2021, 7 citations), he demonstrated that immediate post-operative PDE5i therapy significantly improves early erectile function outcomes, offering a practical, patient-centered strategy for preserving quality of life. He also advanced perioperative care by developing new recommendations to reduce unnecessary blood tests after RARP (2021, 3 citations), promoting cost-effective, evidence-based practices that minimize patient burden without compromising safety. With cumulative citations reflecting growing clinical interest, Rashid’s research bridges surgical technique and functional rehabilitation, directly informing urologists’ decision-making. His work is particularly notable for its focus on early intervention and streamlined post-operative care, making him a valuable voice in the ongoing effort to enhance recovery and patient satisfaction after prostate cancer surgery.

Research Focus

Key Achievements

2
H-Index
3
Papers
12
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Immediate post-operative PDE5i therapy improves early erectile function outcomes after robot assisted radical prostatectomy (RARP)
7 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: University of Cambridge

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago